Stay updated on Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The NIH banner about updates to terminology for artificial intelligence was removed from the page.
    Difference
    1%
    Check dated 2026-11-08T14:20:18.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study record content remains unavailable behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T15:41:43.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A sitewide banner announces an NIH terminology transition from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T14:49:20.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.1 to v3.7.2. The page otherwise displays a 403 Forbidden error instead of study details.
    Difference
    0.2%
    Check dated 2026-10-18T15:12:11.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision label changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-11T14:45:00.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, with standard site chrome around it, indicating restricted access rather than the study content.
    Difference
    21%
    Check dated 2026-09-20T19:55:25.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Axitinib vs Sunitinib in Renal Cell Carcinoma Clinical Trial page.